PAUL HARTMANN AG has acquired Whitestone Acquisition Corp.
The private shareholders of Whitestone Acquisition Corp. have sold the company to PAUL HARTMANN AG (HARTMANN). Financial details have not been disclosed.
HARTMANN, headquartered in Heidenheim, Germany, is a worldwide leader in wound management, incontinence management and risk prevention products in the operating room. Together with the existing US subsidiary, HARTMANN-Conco, Inc. in Rock Hill, South Carolina, HARTMANN consolidates its position in the nursing home and home care sector, the most important market for incontinence products. With this acquisition, the USA will become the third largest market for HARTMANN after Germany and France. The company also sees great opportunities for the establishment of system solutions for inpatient and outpatient care.
Whitestone Acquisition Corp., based in Bloomington, Indiana, is a manufacturer of high-quality adult disposable incontinence products such as briefs, liners and underpads. Formed in 1995, Whitestone annually produces and distributes products for over US$40 million. The corporation primarily serves the institutional long-term care and healthcare markets, markets which are growing 7% a year due to demographic trends.
Oaklins' team in Germany advised HARTMANN on the acquisition of Whitestone Acquisition Corp.
Talk to the deal team
Related deals
Rare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreClinical Partners has raised new debt facilities
Clinical Partners Ltd. has successfully restructured and upsized its debt facilities to better reflect the scale of the business. The company increased its original US$9.4 million facility, comprising a US$3.4 million term loan and a US$6 million revolving credit facility (RCF), to a US$27 million RCF.
Learn more